217 related articles for article (PubMed ID: 11952552)
41. Ichthyosis Linearis Circumflexa as the Only Clinical Manifestation of Netherton Syndrome.
Guerra L; Fortugno P; Pedicelli C; Mazzanti C; Proto V; Zambruno G; Castiglia D
Acta Derm Venereol; 2015 Jul; 95(6):720-4. PubMed ID: 25710899
[TBL] [Abstract][Full Text] [Related]
42. Establishment of a mouse model of Netherton syndrome based on CRISPR/Cas9 technology.
Guo JZ; Su J; Dai H; Wang XY; Wu WB; Chen T; Zhang J; Wang WH
Eur J Dermatol; 2022 Jul; 32(4):459-463. PubMed ID: 36301754
[TBL] [Abstract][Full Text] [Related]
43. Molecular analysis of a series of Israeli families with Comèl-Netherton syndrome.
Israeli S; Sarig O; Garty BZ; Indelman M; Bergman R; Sprecher E; Goldberg I
Dermatology; 2014; 228(2):183-8. PubMed ID: 24577329
[TBL] [Abstract][Full Text] [Related]
44. Comèl-Netherton syndrome defined as primary immunodeficiency.
Renner ED; Hartl D; Rylaarsdam S; Young ML; Monaco-Shawver L; Kleiner G; Markert ML; Stiehm ER; Belohradsky BH; Upton MP; Torgerson TR; Orange JS; Ochs HD
J Allergy Clin Immunol; 2009 Sep; 124(3):536-43. PubMed ID: 19683336
[TBL] [Abstract][Full Text] [Related]
45. The challenging management of a series of 43 infants with Netherton syndrome: unexpected complications and novel mutations.
Bellon N; Hadj-Rabia S; Moulin F; Lambe C; Lezmi G; Charbit-Henrion F; Alby C; Le Saché-de Peufeilhoux L; Leclerc-Mercier S; Hadchouel A; Steffann J; Hovnanian A; Lapillonne A; Bodemer C
Br J Dermatol; 2021 Mar; 184(3):532-537. PubMed ID: 32479644
[TBL] [Abstract][Full Text] [Related]
46. Netherton syndrome with ichthyosis linearis circumflexa and trichorrhexis invaginatum.
Ng E; Hale CS; Meehan SA; Cohen DE
Dermatol Online J; 2014 Dec; 20(12):. PubMed ID: 25526335
[TBL] [Abstract][Full Text] [Related]
47. Netherton syndrome and trichorrhexis invaginata--a novel diagnostic approach.
Burk C; Hu S; Lee C; Connelly EA
Pediatr Dermatol; 2008; 25(2):287-8. PubMed ID: 18429812
[No Abstract] [Full Text] [Related]
48. Intrafamily and Interfamilial Phenotype Variation and Immature Immunity in Patients With Netherton Syndrome and Finnish SPINK5 Founder Mutation.
Hannula-Jouppi K; Laasanen SL; Ilander M; Furio L; Tuomiranta M; Marttila R; Jeskanen L; Häyry V; Kanerva M; Kivirikko S; Tuomi ML; Heikkilä H; Mustjoki S; Hovnanian A; Ranki A
JAMA Dermatol; 2016 Apr; 152(4):435-42. PubMed ID: 26865388
[TBL] [Abstract][Full Text] [Related]
49. rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients.
Roedl D; Oji V; Buters JT; Behrendt H; Braun-Falco M
J Dermatol Sci; 2011 Mar; 61(3):194-8. PubMed ID: 21251800
[TBL] [Abstract][Full Text] [Related]
50. NETHERTON'S DISEASE; TRICHORRHEXIS INVAGINATA (BAMBOO HAIR), CONGENITAL ICHTHYOSIFORM ERYTHRODERMA AND THE ATOPIC DIATHESIS. A HISTOPATHOLOGIC STUDY.
WILKINSON RD; CURTIS GH; HAWK WA
Arch Dermatol; 1964 Jan; 89():46-54. PubMed ID: 14070837
[No Abstract] [Full Text] [Related]
51. Phase I study protocol for ex vivo lentiviral gene therapy for the inherited skin disease, Netherton syndrome.
Di WL; Mellerio JE; Bernadis C; Harper J; Abdul-Wahab A; Ghani S; Chan L; Martinez-Queipo M; Hara H; McNicol AM; Farzaneh F; McGrath J; Thrasher A; Qasim W
Hum Gene Ther Clin Dev; 2013 Dec; 24(4):182-90. PubMed ID: 24329107
[TBL] [Abstract][Full Text] [Related]
52. Penile cancer in a man with netherton syndrome.
Isharwal S; Manivel JC; Konety B
Urology; 2015 Apr; 85(4):e21-2. PubMed ID: 25817126
[TBL] [Abstract][Full Text] [Related]
53. Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome.
Hachem JP; Wagberg F; Schmuth M; Crumrine D; Lissens W; Jayakumar A; Houben E; Mauro TM; Leonardsson G; Brattsand M; Egelrud T; Roseeuw D; Clayman GL; Feingold KR; Williams ML; Elias PM
J Invest Dermatol; 2006 Jul; 126(7):1609-21. PubMed ID: 16601670
[TBL] [Abstract][Full Text] [Related]
54. SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
Wang S; Olt S; Schoefmann N; Stuetz A; Winiski A; Wolff-Winiski B
Exp Dermatol; 2014 Jul; 23(7):524-6. PubMed ID: 24848304
[TBL] [Abstract][Full Text] [Related]
55. Hair abnormality in Netherton syndrome observed under polarized light microscopy.
Utsumi D; Yasuda M; Amano H; Suga Y; Seishima M; Takahashi K
J Am Acad Dermatol; 2020 Sep; 83(3):847-853. PubMed ID: 32029302
[TBL] [Abstract][Full Text] [Related]
56. The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role.
Mägert HJ; Kreutzmann P; Drögemüller K; Ständker L; Adermann K; Walden M; John H; Korting HC; Forssmann WG
Eur J Med Res; 2002 Feb; 7(2):49-56. PubMed ID: 11891144
[TBL] [Abstract][Full Text] [Related]
57. Netherton syndrome associated with growth hormone deficiency.
Aydın BK; Baş F; Tamay Z; Kılıç G; Süleyman A; Bundak R; Saka N; Özkaya E; Güler N; Darendeliler F
Pediatr Dermatol; 2014; 31(1):90-4. PubMed ID: 24015757
[TBL] [Abstract][Full Text] [Related]
58. Netherton syndrome and its multifaceted defective protein LEKTI.
D'Alessio M; Fortugno P; Zambruno G; Hovnanian A
G Ital Dermatol Venereol; 2013 Feb; 148(1):37-51. PubMed ID: 23407075
[TBL] [Abstract][Full Text] [Related]
59. Trichoscopy as a diagnostic tool in trichorrhexis invaginata and Netherton syndrome.
Bittencourt Mde J; Moure ER; Pies OT; Mendes AD; Deprá MM; Mello AL
An Bras Dermatol; 2015; 90(1):114-6. PubMed ID: 25672309
[TBL] [Abstract][Full Text] [Related]
60. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome.
Bitoun E; Micheloni A; Lamant L; Bonnart C; Tartaglia-Polcini A; Cobbold C; Al Saati T; Mariotti F; Mazereeuw-Hautier J; Boralevi F; Hohl D; Harper J; Bodemer C; D'Alessio M; Hovnanian A
Hum Mol Genet; 2003 Oct; 12(19):2417-30. PubMed ID: 12915442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
